Skip to content

The Immune indicator in PLWH under Maintenance Hemodialysis in Sichuan: A Prospective Observational Study

The Immune indicator in PLWH under Maintenance Hemodialysis in Sichuan: A Prospective Observational Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091753
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV

Interventions

Maintenance Hemodialysis group:none.

Sponsors

The Public Health Clinical Center of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. diagnosised with HIV infection. 2. Taking Highly Active Antiretroviral Therapy (HAART) for more than 6 months and undetectable HIV-RNA levels (<50 copies/ml) within the past 3 months. 3. over 18 years or above, with no gender restrictions. 4. Capable of understanding and providing written informed consent. 5. Demonstrates good compliance and is able to cooperate in completing all required examinations and follow-ups during the study period.

Exclusion criteria

Exclusion criteria: 1. History of organ transplantation, active malignant tumors, or other severe complications. 2. Received immunosuppressive therapy or chemotherapy within the last 3 months prior to baseline visit. 3. Anticipated receipt of these medications or continuous steroid therapy during the study period. 4. Pregnant or lactating women. 5. Patients with unstable mental states or cognitive impairments. 6. Any other conditions deemed unsuitable for study participation by the investigator.

Design outcomes

Primary

MeasureTime frame
Complete Blood Count ;C-Reactive Protein;

Secondary

MeasureTime frame
T-Lymphocyte Count;HIV-RNA Viral Load;

Countries

China

Contacts

Public ContactDongmei Yan

The Public Health Clinical Center of Chengdu

15982491863@163.com+86 159 8249 1863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026